GHISLAINE MAXWELL - OAP ifID ACCT.
For die Period 3/1/14 to 3/31/14
Equity Summary
Beginning Ending Change Current
Asset Categories Market Value Market Value In Value Allocation
EAFE Equity 137,528.10 0.00 (137,528.10)
Equity Detail
Adjusted Tax Cost Unrealized Est. Annual Inc.
Pnce Quantity Value Original Cost Gain/Loss Accrued Div. Yield
EA FE Equity
GLAXOSMITHKLINE PLC 53.43 0.00 4.62%
SPONS ADR 684.77
37733W-10-5 GSK
KIRIN HOLDINGS COMPANY LTD 13.85 0.00 2.00%
SPONS ADR 476.23
497350-30-6 KNBW
FtECKITT BENCKISER GROUP PLC 16.48 0.00 2.57%
SPONSORED ADR 776.95
756255-20-4 RBGL
Total WE Equity $0.00 S0.00 $0.00 $0.00 0.00%
$1.937.95
JP Morgan Page 3 of 7
Confidential Treatment Requested by JPMorgan JPM-SDNY-00046778
Chase
CONFIDENTIAL SDNY_GM_00315976
EFTA01519491